CiteFacts · FDA Drug Shortages · FDA source

Furosemide Injection

FDA shortage status · Source checked 2026-08-22T15:54:11+00:00

Status

FDA currently lists this ingredient in shortage.

This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.

FDA package and manufacturer records

CompanyPresentationFDA availability fieldFDA update
Accord Healthcare Inc.Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08)Unavailable08/17/2026
Accord Healthcare Inc.Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43)Unavailable08/17/2026
Accord Healthcare Inc.Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43)Unavailable08/17/2026
Avet Pharmaceuticals, Inc.Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41)Available08/18/2026
Avet Pharmaceuticals, Inc.Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42)Unavailable08/18/2026
Avet Pharmaceuticals, Inc.Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44)Unavailable08/18/2026
Baxter HealthcareFurosemide, Injection, 10 mg/1 mL (NDC 36000-282-25)Available08/17/2026
Baxter HealthcareFurosemide, Injection, 10 mg/1 mL (NDC 36000-283-25)Available08/17/2026
Baxter HealthcareFurosemide, Injection, 10 mg/1 mL (NDC 36000-284-25)Available08/17/2026
Eugia US LLCFurosemide, Injection, 100 mg/10 mL (NDC 55150-324-25)Available08/06/2026
Eugia US LLCFurosemide, Injection, 20 mg/2 mL (NDC 55150-322-25)Unavailable08/06/2026
Eugia US LLCFurosemide, Injection, 40 mg/4 mL (NDC 55150-323-25)Available08/06/2026
Fresenius Kabi USA, LLCFurosemide, Injection, 10 mg/1 mL (NDC 63323-280-02)Available08/04/2026
Fresenius Kabi USA, LLCFurosemide, Injection, 10 mg/1 mL (NDC 63323-280-04)Available08/04/2026
Fresenius Kabi USA, LLCFurosemide, Injection, 10 mg/1 mL (NDC 63323-280-10)Available08/04/2026
Gland Pharma LimitedFurosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)Unavailable07/22/2026
Gland Pharma LimitedFurosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)Not stated04/28/2026
Gland Pharma LimitedFurosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)Unavailable07/22/2026
Gland Pharma LimitedFurosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)Not stated04/28/2026
Gland Pharma LimitedFurosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)Unavailable07/22/2026
Gland Pharma LimitedFurosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)Not stated04/28/2026
Hospira, Inc., a Pfizer CompanyFurosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10)Available08/07/2026
Hospira, Inc., a Pfizer CompanyFurosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27)Next Delivery and Estimated Recovery: December 202808/07/2026
Hospira, Inc., a Pfizer CompanyFurosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02)Available08/07/2026
Hospira, Inc., a Pfizer CompanyFurosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25)Unavailable08/07/2026
Hospira, Inc., a Pfizer CompanyFurosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04)Available08/07/2026
Hospira, Inc., a Pfizer CompanyFurosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26)Unavailable08/07/2026
Meitheal Pharmaceuticals, Inc.Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-05)Available04/23/2026
Meitheal Pharmaceuticals, Inc.Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-11)Available04/23/2026
Meitheal Pharmaceuticals, Inc.Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03)Available04/23/2026

Source facts

Grouped generic ingredient: Furosemide Injection · 30 package records · Latest FDA row update: 08/18/2026

Therapeutic categories: Cardiovascular
Dosage forms: Injection
Routes: INTRAMUSCULAR, INTRAVENOUS

Open FDA source data · JSON · Markdown

FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.